gastric inhibitory peptide is secreted by GIP is secreted from K cells located in the upper small intestine - Gastric inhibitory peptidemedication secreted from the proximal small gut Unveiling the Source: Where Gastric Inhibitory Peptide is Secreted From

Gastric inhibitory peptidemedication Gastric inhibitory peptide (GIP), also widely recognized as glucose-dependent insulinotropic polypeptide, is a crucial peptide hormone that plays a significant role in metabolic regulation. Understanding its origin is fundamental to grasping its physiological functions. The primary answer to the question of gastric inhibitory peptide is secreted by lies within the upper small intestine作者：S Yamane·2016·被引用次数：49—GIP is secreted from K cells located in the upper small intestine; GLP-1 is secreted from L cells located in the lower small intestine and colon ....

Specifically, GIP is synthesized and released by the K-cells of the duodenum and proximal jejunum. These specialized cells, known as enteroendocrine K cells, are embedded within the mucosal lining of the upper section of the small intestine. The process begins with the proteolytic processing of pre-pro GIP, ultimately leading to the mature GIP hormone. These K cells are strategically positioned to detect nutrients absorbed from ingested food, initiating the release of GIP into the bloodstream.

The secretion of GIP is intricately linked to the presence of nutrients, particularly carbohydrates and fats, in the digestive tract. When food, especially glucose or fat, enters the duodenum, it acts as a potent stimulus for GIP release. This phenomenon is a key component of the incretin effect, a physiological response where oral glucose triggers a greater insulin secretion than intravenous glucose administration. GIP is a major player in this effect, hence its name: glucose-dependent insulinotropic polypeptide.

Beyond its primary source in the duodenum and jejunum, research has also indicated that GIP can be expressed in pancreatic islet alpha-cells, though its primary role and secretion dynamics from these cells are less understood compared to its intestinal origins.2004年12月1日—The two hormones responsible for the incretin effect, glucose-dependent insulinotropic hormone (GIP) and glucagon-like peptide-1 (GLP-1), are secreted after ... Furthermore, GIP is released from the precursor molecule through specific enzymatic cleavage, a common mechanism for peptide hormone maturation.

The journey of GIP from its origin in the proximal small intestine to its target tissues is rapid.Gastric inhibitory polypeptide (GIP) dose-dependently ... Following its secretion into the circulation, GIP exerts its effects, most notably by stimulating insulin secretion from pancreatic beta-cells in a glucose-dependent manner2024年7月25日—Gastric Inhibitory Peptide (GIP) is a hormoneproduced in the small intestinethat plays a crucial role in regulating insulin secretion and .... This means that GIP's ability to enhance insulin release is more pronounced when blood glucose levels are elevated. While originally identified for its potential to inhibit gastric acid secretion and motility, hence the name gastric inhibitory polypeptide, its insulinotropic action is now considered its principal physiological function. The term gastric inhibitory polypeptide itself reflects early observations, but the broader understanding of its role has evolved.

In essence, the answer to "where is gastric inhibitory peptide secreted from?" is definitively the K cells located in the duodenum and proximal jejunum of the small intestine. This precise anatomical location and the cellular origin from enteroendocrine K cells highlight the direct link between nutrient intake and the subsequent hormonal signaling that helps regulate glucose homeostasis and overall metabolism. The continuous secretion of GIP in response to meals ensures that the body can efficiently manage postprandial glucose excursions by promoting appropriate insulin release. Understanding this fundamental aspect of GIP physiology is crucial for comprehending its role in health and disease, including conditions like type 2 diabetes, where incretin hormone function can be impaired.